Crossmark

Ozurdex (dexamethasone intravitreal implant) for the treatment of intermediate, posterior, and panuveitis: a systematic review of the current evidence

Crossref DOI link: https://doi.org/10.1186/s12348-019-0189-4

Published Online: 2020-01-10

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Saincher, Saanwalshah Samir http://orcid.org/0000-0002-5865-9874
Gottlieb, Chloe
Funding

Funding for this research was provided by:

The Ottawa Hospital Research Institute
License Information

Text and Data Mining valid from 2020-01-10

Version of Record valid from 2020-01-10
More Information

Article History

Received: 9 May 2019

Accepted: 18 November 2019

First Online: 10 January 2020

Ethics approval and consent to participate

: Not Applicable

: Not Applicable

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below